D A Prasanna is ACRO India's new Chairman

Singapore: On January 10 2014, members of Association of Contract Research Organizations (ACRO INDIA) met and Mr D A Pra...

January 16, 2014 | Thursday | News
Indian govt to revoke suspension of Pioglitazone

New Delhi: A month after the Indian government banned the popular anti-diabetes drug Pioglitazone, it is now planning to...

July 24, 2013 | Wednesday | News
India announces new biosimilar regulatory guidelines

Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been...

June 19, 2012 | Tuesday | Regulatory
Asia biologics manufacturers face the 'quality challenge'

Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy...

March 7, 2012 | Wednesday | News
Indian market expected to grow 12% during 2011-15

New Delhi: The global business intelligence firm, ResearchandMarket has filed their latest report with their projections...

August 1, 2013 | Thursday | News
FDA approves Italian facility of India's Strides Arcolab

Singapore: India's leading drug firm Strides Arcolab, with an agenda to foray into the semi-solid market in the US, has ...

September 19, 2013 | Thursday | News
Digital healthcare, the next big thing

A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies w...

August 7, 2013 | Wednesday | Opinion
Ranbaxy to sell vaccine business Biovel after facing loss

Bangalore: Ranbaxy is going to exit its Bangalore-based vaccine manufacturing company, Biovel, according to Business Sta...

November 26, 2013 | Tuesday | News
LifeCell gets $7 mn funding from Helion Venture

Bangalore: LifeCell International, India's largest and most accredited stem cell bank, secured an investment of $7 milli...

February 21, 2013 | Thursday | News
What makes a country competitive for a clinical research?

Any regulatory body's primary concern is to provide safe and efficacious medicine at an acceptable healthcare cost to ...

September 5, 2013 | Thursday | Opinion
Dr. Reddy's intends to buy Dutch firm

Hyderabad: Dr. Reddy's Laboratories, together with its subsidiaries, announced the intended public offer to acquire the...

October 23, 2012 | Tuesday | News
Sudha Rao: Your decisions are milestones of your life's journey

I completed my graduation and post graduation from the University of Mysore. My first job, after my post doctoral studie...

March 8, 2013 | Friday | Influencers
Sigma-Tau wins coveted MMV anti-malarial award

New Delhi: The project team for Eurartesim, dihydroartemisinin-piperaquine (DHA-PQP), the first novel chemical entity d...

November 28, 2012 | Wednesday | News
Orchid exits 10-year-old JV in China due to competition

Chennai: Chennai-based global pharma major, Orchid Chemicals and Pharmaceuticals has exited its 50:50 manufacturing joi...

November 15, 2012 | Thursday | News
Novel therapeutic from CSIR gets go ahead for trial

New Delhi: The Drugs Controller General of India (DCGI) has cleared the clot-specific streptokinase (CSSK), a pioneering...

August 27, 2012 | Monday | News
Cipla appoints Frank Pieters as head of European region

Mumbai: Cipla, one of India's leading pharmaceutical companies announced the appointment of Mr Frank Pieters as the head...

July 3, 2012 | Tuesday | News
New Japanese encephalitis vaccine in India

Bangalore: Intercell has partnered with Biological E to launch JEEV, a vaccine designed to protect children and adults ...

September 14, 2012 | Friday | News
What are the hurdles before stem cell research?

The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...

January 31, 2013 | Thursday | Analysis